Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease

Anurag Mehta,Shivang R. Desai,Yi-An Ko,Chang Liu,Devinder S. Dhindsa,Aditi Nayak,Ananya Hooda,Mohamed A. Martini,Kiran Ejaz,Laurence S. Sperling,Jochen Reiser,Salim S. Hayek,Arshed A. Quyyumi

Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease

2020

Anurag Mehta
Shivang R. Desai
Yi-An Ko
Chang Liu
Devinder S. Dhindsa
Aditi Nayak
Ananya Hooda
Mohamed A. Martini
Kiran Ejaz
Laurence S. Sperling
Jochen Reiser
Salim S. Hayek
Arshed A. Quyyumi

Background Women have higher circulating levels of soluble urokinase‐type plasminogen activator receptor (suPAR), and elevated suPAR is associated with cardiovascular risk. The independent associat...

Keywords:

SuPAR
Biomarker (medicine)
Gastroenterology
adverse outcomes
Receptor
Internal medicine
Medicine
Cardiology
Urokinase
Plasminogen activator
Coronary artery disease
Diabetes mellitus
Hazard ratio
Confounding
Proportional hazards model
Asymptomatic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations